Form 4: OptimizeRx Executive Stephen Silvestro Reports Acquisition of Restricted Stock Units

Stephen Silvestro, Chief Commercial Officer of OptimizeRx Corp, reports the acquisition of 7,750 restricted stock units.

Summary

• On March 15, 2024, Stephen L Silvestro, Chief Commercial Officer of OptimizeRx Corp, acquired 7,750 shares of common stock in the form of restricted stock units.
• These restricted stock units represent a contingent right to receive shares of OptimizeRx common stock.
• The restricted stock units will vest in full on February 15, 2025, which is the first anniversary of the date of grant.
• Following the transaction, Silvestro directly owns 13,706 shares of OptimizeRx common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing regarding stock ownership. The acquisition of stock units by an executive is generally viewed as a slightly positive sign, but it's not a major event.

Positives

• The acquisition of restricted stock units by a key executive could be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment, as it indicates an executive's investment in the company's future.

Key Dates